JCO oncology practice 2024 Mar 12
Tailoring Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Recent Advances and Strategies.
ABSTRACT
Neoadjuvant HER2 Therapy: Beyond one-size-fits-all.
Related Questions
New answer by Medical Oncologist at Avita Health System (August 28, 2024)
I am not aware of extensive data. I do see a couple of case reports: Pellegrino et al., PMID 29083340. There is a nice summary of chemotherapy for HER2 disease provided by ASC...